U.S. market Closed. Opens in 5 hours 3 minutes

MIRA | MIRA Pharmaceuticals, Inc. Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 1.1300 - 1.4049
52 Week Range 0.5100 - 5.01
Beta N/A
Implied Volatility N/A
IV Rank N/A
Day's Volume 682,372
Average Volume 2,049,033
Shares Outstanding 16,266,148
Market Cap 20,576,677
Sector Healthcare
Industry Drug Manufacturers - General
IPO Date 2023-08-14
Valuation
Profitability
Growth
Health
P/E Ratio -2.30
Forward P/E Ratio N/A
EPS -0.55
1YR Price Target N/A
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 2
Country USA
Website MIRA
MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company focuses on the development and commercialization of a new molecular synthetic tetrahydrocannabinol (THC) analog under investigation for the treatment of adult patients with anxiety and cognitive decline typically associated with early-stage dementia. It is developing MIRA1a, a synthetic cannabinoid analog to treat anxiety and chronic pain by targeting the cannabinoid type 1 and type 2 receptors. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Baltimore, Maryland.
*Chart delayed
Analyzing fundamentals for MIRA we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is very weak. For more detailed analysis please see MIRA Fundamentals page.

Watching at MIRA technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, but short-term trend is bearish. More technicals details can be found on MIRA Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙